SIRT6 overexpression induces massive apoptosis in cancer cells but not in normal cells

 Abstract

Emerging evidence suggests that Sirtuin 6 (SIRT6) functions as a longevity assurance gene by promoting genomic stability, regulating metabolic processes and attenuating inflammation. Here, we examine the effect of SIRT6 activation on cancer cells. We show that SIRT6 overexpression induces massive apoptosis in a variety of cancer cell lines but not in normal, non-transformed cells. This cell death requires the mono-ADP-ribosyltransferase but not the deacetylase activity of SIRT6 and is mediated by the activation of both the p53 and p73 apoptotic signaling cascades in cancer cells by SIRT6. These results suggest that SIRT6 is an attractive target for pharmacological activation in cancer treatment.

Full Text Options
Article
Metrics
 Share
 Full Text
 Info
Pages
3153 - 3158
doi
10.4161/cc.10.18.17435
Type
Report
 Metrics
 Cite This Article
 Permissions
 Permissions
 Reprints
SIRT6 overexpression induces massive apoptosis in cancer cells but not in normal cells